ROCHE HIVID 0.750 (Hivid 0.75 mg)

Generic Name: zalcitabine

Pill imprint ROCHE HIVID 0.750 has been identified as Hivid 0.75 mg.

Hivid is used in the treatment of hiv infection and belongs to the drug class nucleoside reverse transcriptase inhibitors (NRTIs). Risk cannot be ruled out during pregnancy. Hivid 0.75 mg is not subject to the Controlled Substances Act.

See also related documents.

Imprint Search

Images for ROCHE HIVID 0.750

Hivid 0.75 mg ROCHE HIVID 0.750
Hivid 0.75 mg ROCHE HIVID 0.750
Hivid
Generic Name:
zalcitabine
Imprint:
ROCHE
HIVID 0.750
Strength:
0.75 mg
Color:
White
Size:
11.00 mm
Shape:
Elliptical / Oval
Availability:
Prescription only
Drug Class:
Nucleoside reverse transcriptase inhibitors (NRTIs)
Pregnancy Category:
C - Risk cannot be ruled out
CSA Schedule:
N - Not a controlled drug
Manufacturer:
Roche Laboratories
National Drug Code (NDC):
00004-0221

View Details Print Page

Disclaimer: Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.

Copyright 2014 Drugs.com, National Library of Medicine, Truven Health Analytics and Cerner Multum, Inc. All Rights Reserved.

Hide
(web2)